Last Updated on February 17, 2026 by Olasunkanmi Olajide
By Patrick Erinoso
A Chief Consultant Urologist and Urological Surgeon at the Federal Medical Centre, Idi-Aba, Dr. Chidi Ebere, has called for improved and expanded access to early prostate cancer screening for men across Nigeria.
Dr. Ebere made the call on February 12, 2026, during a Prostate Cancer Awareness Campaign organised for men at the Federal University of Agriculture, Abeokuta (FUNAAB). He described prostate cancer as the most common cancer affecting men in Nigeria and one of the leading causes of cancer-related deaths among them.

Underscoring the gravity of the disease, the Consultant Urologist disclosed that statistics show that approximately one in every four to six men may develop prostate cancer in their lifetime. While describing the figures as alarming, he emphasised that the disease is highly treatable when detected early.
According to him, early detection remains the most effective strategy for reducing mortality associated with prostate cancer. He therefore advocated intensified public enlightenment on prostate health and encouraged routine screening, particularly for men within high-risk age groups.

Dr. Ebere explained that screening procedures include blood tests to assess Prostate-Specific Antigen (PSA) levels and digital rectal examinations to detect abnormalities in the prostate gland. After the screening, Dr. Ebere said that the participants also underwent comprehensive health evaluations aimed at identifying individuals at elevated risk.
He stressed that individuals identified as high-risk were appropriately counselled, while those with detected abnormalities were guided on accessing specialised medical care to ensure timely and effective treatment.

At the end of the exercise, a total of 149 members of staff participated in the screening programme.
Dr. Ebere reaffirmed that the primary objective of the initiative was to promote early detection, provide professional medical guidance, and ensure that individuals diagnosed with prostate cancer receive prompt and adequate care.